Study Insights Underscore Cleerly’s Focus on Sex-Specific Cardiovascular Risk

According to a recent LinkedIn post from Cleerly, the company is drawing attention to findings from the CONFIRM2 study that highlight sex-specific differences in coronary plaque risk. The post notes that with roughly 50% female participation across 12 countries, certain coronary plaque features appear associated with a higher risk of major adverse cardiac events in women than in men.

The post suggests that more representative, gender-balanced datasets could support a shift away from one-size-fits-all cardiovascular risk models toward more tailored prevention strategies for women. For investors, this emphasis on health equity and women’s heart health may reinforce Cleerly’s positioning in AI-enabled cardiac imaging and risk stratification, potentially enhancing its relevance to clinical guideline evolution and payer interest over time.